Notice of Results

RNS Number : 2678G

Hutchison China Meditech Limited

28 June 2012

 



Hutchison China MediTech Limited ("Chi-Med")

(AIM: HCM)

Notice of Announcement of 2012 Interim Results

London: Thursday, 28 June 2012: Chi-Med will be announcing its interim results for the six months ended 30 June 2012 on Tuesday, 31 July 2012.  An analyst presentation will be held at 9:30 am on the same day at Citigate Dewe Rogerson, 3 London Wall Buildings, London, EC2M 5SY.

Ends

Enquiries

Chi-Med Christian Hogg, CEO	Telephone:      [phone]
Citigate Dewe Rogerson Anthony Carlisle David Dible	Telephone:      [phone] Mobile:             [phone] Mobile:             [phone]
Lazard & Co., Limited Paul Gismondi Nick Fowler	Telephone:      [phone]

About Chi-Med

Chi-Med is the holding company of a healthcare group based primarily in China and was listed on the Alternative Investment Market of the London Stock Exchange in May 2006.  It is focused on researching, developing, manufacturing and selling pharmaceuticals and health oriented consumer products.

Chi-Med is majority owned by Hutchison Whampoa Limited, an international company listed on the Main Board of The Stock Exchange of Hong Kong Limited.

 

END

 

 

NORZMGZVMNMGZZM